BMS-351 - CAS 1370001-71-0

BMS-351 is a potent and selective, nonsteroidal CYP17A1 lyase inhibitor with robust selectivity over steroidogenic CYPs 21A2 and 11B1. BMS-351 emerges as an outstanding preclinical candidate to treat CRPC and is likely to minimize the side effects of current therapies due to its exceptional selectivity. BMS-351 is potentially useful for the Treatment of Prostate Cancer.

Cytochromes P450, Others

Others, Metabolism

1369930

C15H12F3N3

291.27

C(C(F)(F)F)N1C=2C(=C(C=CC2)C=3C(C)=CC=NC3)N=C1

-20°C

Ice Packs

Small Compound